Open Access
CC BY 4.0 · Rev Bras Ginecol Obstet 2021; 43(04): 339-340
DOI: 10.1055/s-0041-1729948
Letter to the Editor

Twelve Months Down the Line: do we know Anything more about the Presence of the SARS-CoV-2 in Human Semen?

1   Reproduction Group, Department of Microbiology and Parasitology, Medical School, University of Antioquia, Antioquia, Colombia
,
2   Department of Basic Sciences, College of Medicine, Mohammed Bin Rashid University of Medicine and Health Sciences, Dubai, United Arab Emirates
› Institutsangaben
 

Dear Editor,

During the last year, the SARS-CoV-2 infectious agent of COVID-19 has caused more than 75 million infections and 1.5 million deaths worldwide. It has been observed to affect the respiratory tract and exert multiple effects on the human body, including the male reproductive tract. To date, it is understood that although the general infection rate is similar in men and women (50%), deaths in the male population are higher.[1] It has even been reported that the prostate expresses the virus receptor, which could negatively affect the seminal quality and could have a severe effect on human reproduction.[2] [3] Therefore, this commentarýs objective was to analyze the scientific data published to date on the presence of the virus in semen.

A literature search of the PubMed and Google Scholar databases was performed using the following keywords: COVID-19, SARS-CoV-2, seminal, semen, and sperm. To date, only fourteen articles (both originals and case report)[4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] described on the presence of the virus in semen samples. Of these, only a single study described to have identified the virus to be present in six semen samples from SARS-CoV-2 positive patients.[4] None of the remaining 13 studies detected the virus in the semen of 351 COVID-19 positive men ([Fig. 1]).

Zoom
Fig. 1 SARS-CoV-2 in semen samples. Total semen samples (the size of each bubble is proportional), positive samples, and date publication (color).

Based on current evidence, although the virus could be causing adverse effects in the male reproductive tract, its presence in semen continues to be debated because current evidence suggests that the probability of being in semen is very low (1.68%). Consequently, the likelihood of infection through sexual intercourse would be extremely weak. Therefore, as a matter of urgency, further studies on this matter should be pursued.


Conflicts to Interest

None to declare.


Address for correspondence

Walter Cardona Maya
Cl. 67 ##53-108, Medellín, Antioquia
Colômbia   

Publikationsverlauf

Eingereicht: 14. Februar 2021

Angenommen: 16. März 2021

Artikel online veröffentlicht:
12. Mai 2021

© 2021. Federação Brasileira de Ginecologia e Obstetrícia. This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/)

Thieme Revinter Publicações Ltda.
Rua do Matoso 170, Rio de Janeiro, RJ, CEP 20270-135, Brazil


Zoom
Fig. 1 SARS-CoV-2 in semen samples. Total semen samples (the size of each bubble is proportional), positive samples, and date publication (color).